Notes
![]() ![]() Notes - notes.io |
Treatment for locally advanced differentiated thyroid cancer is surgery followed by radioiodine while the role of adjuvant external beam radiotherapy (EBRT) is debated.
The panel of the Italian Association of Radiotherapy and Clinical Oncology developed a clinical recommendation on the addition of EBRT to radioiodine after surgery for locally advanced differentiated thyroid cancer by using the Grades of Recommendation, Assessment, Development, and Evaluation methodology and the Evidence to Decision framework. A systematic review with meta-analysis about this topic was conducted with a focus on outcome of benefits and toxicity.
Locoregional control was improved by EBRT while no considerable toxicity impact was reported.
The panel judged uncertain the benefit/harms balance; final recommendation was conditional both for EBRT + radioiodine and radioiodine alone in the adjuvant setting.
The panel judged uncertain the benefit/harms balance; final recommendation was conditional both for EBRT + radioiodine and radioiodine alone in the adjuvant setting.
Extensive debate surrounds the practice of continuous sedation until death within end-of-life care.
To provide insight into existing initiatives to support the practice of continuous sedation until death and assess their feasibility and effectiveness.
Systematic review and narrative synthesis, registered on PROSPERO (CRD42020149630).
Records were searched through MEDLINE, EMBASE, CENTRAL, CINAHL, and Web of Science from inception to April 16 2020. Peer-reviewed studies reporting original data on initiatives to support the practice of continuous sedation were included for review.
Twenty-one studies met the criteria and were included. Initiatives were focused on assessment tools of consciousness and discomfort (9), the use of guidelines and protocols (8), and expert consultation (3). All initiatives were reported as useful, acceptable, and feasible. Studies on the use of monitoring devices showed that a small proportion of patients were found to be awake, despite the patient being unresponsive according to the observer-based sedation scales. However, the wide range of values of these monitoring devices for comfortable and adequately sedated patients seems to hamper its overall implementation in daily clinical practice. Physicians reported changes in practice conform to guideline recommendations but the shift was modest at best. Expert consultation was regarded as supportive when sufficient expertise is lacking and helpful in avoiding possibly unnecessary sedations.
The reviewed initiatives may contribute to improvement of continuous sedation until death, though their evidence base is rather limited. More insight is needed into their feasibility, preconditions for effective implementation and impact in actual practice.
The reviewed initiatives may contribute to improvement of continuous sedation until death, though their evidence base is rather limited. More insight is needed into their feasibility, preconditions for effective implementation and impact in actual practice.The COVID-19 pandemic has drawn attention to aerosol-generating medical procedures (AGMPs) in health care environments as a potential mode of transmission. Many organizations and institutions have published AGMP safety guidelines, and several mention the use of simulation in informing their recommendations; however, current methods used to simulate aerosol generation are heterogenous. Creation of a high-fidelity, easily producible aerosol-generating cough simulator would meet a high-priority educational need across all medical specialties. In this communication, we describe the design, construction, and user study of a novel cough simulator, which demonstrates the utility of simulation in raising AGMP safety awareness for providers of all roles, specialties, and training levels.
A single-nucleotide polymorphism 538G>A in the human
gene is a determinant of the earwax morphotype.
538GG and GA correspond to wet earwax and 538AA to dry earwax. Despite a putative positive correlation between the frequency of the 538G allele and the prevalence of cholesteatoma, minimal clinical information is currently available. We aimed to evaluate this association between the
genotypes and acquired middle ear cholesteatoma.
Case-control study.
Single-center academic hospital.
We recruited 67 Japanese patients with acquired middle ear cholesteatoma (cholesteatoma group) and 100 Japanese controls with no history of middle ear cholesteatoma. We assessed the
genotypes for all participants. Clinical information was collected from the cholesteatoma group. The genotype data of 104 Japanese people from the 1000 Genomes Project who represent the general population were used.
The proportion of participants with
538GG or GA was significantly higher in the cholesteatoma group than in the control group or general Japanese population (
< .001). The
538G allele frequency was also significantly higher in the cholesteatoma group than in the control group or general Japanese population (
< .001). Multivariate logistic regression analyses revealed a significant association between the
genotype and acquired middle ear cholesteatoma (odds ratio, 5.49; 95% CI, 2.61-11.5;
< .001).
Our results suggest that the
genotypes could be associated with the development of acquired middle ear cholesteatoma among Japanese people.
Our results suggest that the ABCC11 genotypes could be associated with the development of acquired middle ear cholesteatoma among Japanese people.The purpose of this study was to examine the effects of listening to pre-exercise music on bench press performance. find more We recruited 10 resistance trained males (M age= 22.8, SD = 5.8 years; M height= 173.7, SD = 8.3 cm; M body mass = 81.0, SD = 18.2 kg) for this crossover counterbalanced research design. Participants completed two bench press exercise trials of (a) No music (NM), and (b) Pre-exercise music (PreExM) separated by at least 48 hours. For each trial, following a warm-up, participants listened to music or no music for three minutes. After this 3-minute period, they completed one set of bench press repetitions with maximum explosive intent at 75% one repetition maximum (1 RPM). We used a rotary encoder to measure power and velocity of barbell movement. After a 3-minute rest during which they again listened to music or no music, participants completed another set of repetitions to failure (RTF) at 75% of 1RM. Immediately following this second set of repetitions, we measured exercise motivation with a visual analog scale (VAS).
Read More: https://www.selleckchem.com/products/rcm-1.html
![]() |
Notes is a web-based application for online taking notes. You can take your notes and share with others people. If you like taking long notes, notes.io is designed for you. To date, over 8,000,000,000+ notes created and continuing...
With notes.io;
- * You can take a note from anywhere and any device with internet connection.
- * You can share the notes in social platforms (YouTube, Facebook, Twitter, instagram etc.).
- * You can quickly share your contents without website, blog and e-mail.
- * You don't need to create any Account to share a note. As you wish you can use quick, easy and best shortened notes with sms, websites, e-mail, or messaging services (WhatsApp, iMessage, Telegram, Signal).
- * Notes.io has fabulous infrastructure design for a short link and allows you to share the note as an easy and understandable link.
Fast: Notes.io is built for speed and performance. You can take a notes quickly and browse your archive.
Easy: Notes.io doesn’t require installation. Just write and share note!
Short: Notes.io’s url just 8 character. You’ll get shorten link of your note when you want to share. (Ex: notes.io/q )
Free: Notes.io works for 14 years and has been free since the day it was started.
You immediately create your first note and start sharing with the ones you wish. If you want to contact us, you can use the following communication channels;
Email: [email protected]
Twitter: http://twitter.com/notesio
Instagram: http://instagram.com/notes.io
Facebook: http://facebook.com/notesio
Regards;
Notes.io Team